Trial · NCT04288778
Adverse events91
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 91
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Lymphopenia | Blood and lymphatic system disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Palpitations | Cardiac disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Sinus Bradycardia | Cardiac disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Sinus Tachycardia | Cardiac disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Hydrocele | Congenital, familial and genetic disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Cataract | Eye disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Diabetic Retinal Oedema | Eye disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Constipation | Gastrointestinal disorders | Canagliflozin + Metformin Hydrochloride FDC | 3 | 274 | |
| other | Diarrhoea | Gastrointestinal disorders | Canagliflozin + Metformin Hydrochloride FDC | 2 | 274 | |
| other | Dyspepsia | Gastrointestinal disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Frequent Bowel Movements | Gastrointestinal disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Gastritis | Gastrointestinal disorders | Canagliflozin + Metformin Hydrochloride FDC | 2 | 274 | |
| other | Hyperchlorhydria | Gastrointestinal disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Stomatitis | Gastrointestinal disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Toothache | Gastrointestinal disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Asthenia | General disorders | Canagliflozin + Metformin Hydrochloride FDC | 5 | 274 | |
| other | Chest Pain | General disorders | Canagliflozin + Metformin Hydrochloride FDC | 1 | 274 | |
| other | Fatigue | General disorders | Canagliflozin + Metformin Hydrochloride FDC | 2 | 274 | |
| other | Pain | General disorders | Canagliflozin + Metformin Hydrochloride FDC | 2 | 274 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04288778/events